The HLA-DR3,DQ2 Heterozygous Genotype is Associated with an Accelerated Progression of Primary Sclerosing Cholangitis

References

• Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430–6.
   PubMed Web of Science ®Google Scholar
• Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100: 1710–7.
   PubMed Web of Science ®Google Scholar
• Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992;103:1893–901.
   PubMed Web of Science ®Google Scholar
• Schrumpf E, Abelnoor M, Fausa O, Elgjo E, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol 1994;21:1061–6.
   PubMed Web of Science ®Google Scholar
• Broomé; U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson Å, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38:610–5.
   PubMed Web of Science ®Google Scholar
• Broomé: U, Eriksson LS. Assessment for liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1994; 20:654–9.
   PubMedGoogle Scholar
• Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, et al. Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992;16:390–5.
   PubMedGoogle Scholar
• Mehal WZ, Lo Y-MD, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994;106: 160–7.
   Google Scholar
• Olerup O, Olsson R, Hultcrantz R, Broomé; U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995;108:870–8.
   Google Scholar
• Schrumpf E, Fausa O, Førre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982;17:187–91.
   Google Scholar
• Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991;13:129–33.
   PubMed Web of Science ®Google Scholar
• Noguchi K, Kobayashi M, Yagihashi A, Yoshida Y, Terasawa K, Konno A, et al. HLA antigens in primary sclerosing cholangitis. Transplant Proc 1992;24:2775–6.
   PubMedGoogle Scholar
• Boberg KM, Schrumpf E, Spurkland A. Increased frequency of HLA-DRB3*0101 (DR52a) associated DQA1, DQB1 haplotypes in primary sclerosing cholangitis. Gut 1994;35 Suppl 4: A45.
   Google Scholar
• Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome; U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 1999;53:459–69.
   Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
   Google Scholar
• Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specifi c primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225–35.
   PubMed Web of Science ®Google Scholar
• Spurkland A, Knutsen I, Markussen G, Vartdal F, Egeland T, Thorsby E. HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support. Tissue Antigens 1993;41:155–64.
   PubMedGoogle Scholar
• Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens 1997;50:15–22.
   PubMedGoogle Scholar
• Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;329:599–604.
   Google Scholar
• Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 1988;85:6012–6.
   PubMed Web of Science ®Google Scholar
• Tsuji K, Aizawa M, Sasazuki T. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford Science Publications; 1992.
   Google Scholar
• Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
   Google Scholar
• Venables WN, Ripley BD. Modern applied statistics with S-PLUS. New York: Springer; 1997.
   Google Scholar
• Therneau TM, Grambsch PM, Fleming TR. Martingale based residuals for survival models. Biometrika 1990;77:147–60.
   Google Scholar
• Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748–52.
   PubMed Web of Science ®Google Scholar
• Tang J, Costello C, Keet IPM, Rivers C, Leblanc S, Karita E, et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type I infection. AIDS Res Hum Retroviruses 1999;15:317–24.
   PubMed Web of Science ®Google Scholar
• Thursz MR, Thomas HC, Greenwood BM, Hill AVS. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997;17:11–2.
   PubMed Web of Science ®Google Scholar
• Reveille JD. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 1998;10:187–200.
   PubMedGoogle Scholar
• Olsen NJ, Callahan LF, Brooks RH, Nance EP, Kaye JJ, Stastny P, et al. Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med 1988; 84:257–64.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89: 2033–9.
   Google Scholar
• Seitz M, Perler M, Pichler W. Only weak association between disease severity and HLA-DRB 1 genes in a Swiss population of rheumatoid arthritis patients. Rheumatol Int 1996;16: 9–13.
   Google Scholar